| Literature DB >> 29709545 |
Munkyung Kim1, Lilly von Muenchow2, Thomas Le Meur1, Benjamin Kueng1, Berangere Gapp1, Delphine Weber1, William Dietrich3, Jiri Kovarik1, Antonius G Rolink2, Iwona Ksiazek4.
Abstract
Dipeptidyl peptidase 9 (DPP9) is a ubiquitously expressed intracellular prolyl peptidase implicated in immunoregulation. However, its physiological relevance in the immune system remains largely unknown. We investigated the role of DPP9 enzyme in immune system by characterizing DPP9 knock-in mice expressing a catalytically inactive S729A mutant of DPP9 enzyme (DPP9ki/ki mice). DPP9ki/ki mice show reduced number of lymphoid and myeloid cells in fetal liver and postnatal blood but their hematopoietic cells are fully functional and able to reconstitute lymphoid and myeloid lineages even in competitive mixed chimeras. These studies demonstrate that inactivation of DPP9 enzymatic activity does not lead to any perturbations in mouse hematopoiesis.Entities:
Keywords: Competitive reconstitution assay; DPP9; DPP9 knock-in enzyme inactive mice; Dipeptidyl peptidase; Hematopoiesis; Hematopoietic stem cells
Mesh:
Substances:
Year: 2018 PMID: 29709545 DOI: 10.1016/j.imlet.2018.04.008
Source DB: PubMed Journal: Immunol Lett ISSN: 0165-2478 Impact factor: 3.685